FDA needs to enhance digital technology
The FDA’s drug regulators want to know everything.
They require pharmaceutical companies to conduct years of testing to prove that experimental medicines are safe and effective.
This rigorous and mostly prudent approach makes perfect sense when evaluating potent biopharmaceutical products.
To read more please log in or subscribe to the digital edition https://www.etypeservices.com/Columbus%20Banner%20PressID355/